# AdvanCell Isotopes Pty Ltd — Form D

AdvanCell Isotopes Pty Ltd of SYDNEY NSW, C3, a company, filed a Form D exempt-offering notice with the SEC on 2023-12-28. The offering totals $10.0M, of which $5.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2023-12-28
- Form: D
- Accession: 0002006018-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $5.0M
- Remaining: $5.0M
- Minimum investment: $5.0M
- Investors: 1
- Date of first sale: 2023-12-07
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-500933

## Issuer

- Name: AdvanCell Isotopes Pty Ltd
- CIK: 0002006018
- Entity type: Corporation
- Jurisdiction: AUSTRALIA
- Incorporated: 2019
- Address: LEVEL 7/167 MACQUAIRE ST, SYDNEY NSW, C3, 2000
- Phone: 978-421-6527

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| Anthony Aiudi | Director | Cambridge, MA |
| Kevin Cameron | Director | Cambridge, MA |
| William Ferris | Director | Sydney NSW, C3 |
| Adrian Paterson | Director | Sydney NSW, C3 |
| Simon Puttick | Director | Sydney NSW, C3 |
| Andrew Adamovich | Executive Officer | Cambridge, MA |
| Simon Puttick | Executive Officer | Sydney NSW, C3 |
| Michael Tung | Executive Officer | San Francisco, CA |

## More

- [CIK 2006018 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2006018&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002006018-23-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.